Dr. Johann Michael Wirsing

Dr. Johann Michael Wirsing

Statements by Employers

Work History

Work History

JM Wirsing Intellectual Property Consulting

Apr 2009 - Present

Owner and Principal Consultant

Since Apr. 2009, I have been providing services to small and medium enterprises, particularly of Biotech provenance, on matters of Intellectual Property.

Nov 2007 - Apr 2008

Senior Patent Counsel

Roche Kulmbach GmbH at the time was a subsidiary of Hoffmann La Roche AG, and was acting as a Center of Excellence for RNAi (RNA-interference) technology within Hoffman La Roche AG. The company was spun-off in 2007 from Alnylam Europe AG, a subsidiary of Alnylam Phamcaeuticals, Inc., Cambridge, MA, USA, the industry leader in this technology. It was my responsibility to monitor scientific progress in the company's laboratories for potentially valuable intellectual property, to facilitate the integration of Roche Kulmbach GmbH into the Hoffman La Roche concern in all aspects regarding intellectual property, and to act as liaison officer to the Hoffman La Roche International Patent Department in Basel.

May 2003 - Oct 2007

Director Intellectual Property

As the first company world wide to focus on RNAi therapeutics, Alnylam Europe AG was formed under the name of Ribopharma AG as a spin-off of the University of Bayreuth, Germany, in June 2000. In July 2003, Ribopharma AG merged with Alnylam Pharmaceuticals Inc. to create the leading RNAi therapeutics company. I joined Ribopharma just prior to this merger, and was thereafter put in charge of Alnylam Europe's Intellectual Property activities. Further on, it was my objective to set up, develop and ultimately lead a proper Patent Department for the company. This included, for example: 

- advising senior management on Intellectual Property matters;

- liaising with and reporting to Alnylam Pharmaceuticals, Inc., on these matters;

- conducting IP due diligence investigations, e.g. for Anylam Pharmaceuticals' initial public offering;

- drafting, filing, prosecution and defence of patent applications and patents before the national and international patent offices;

- ensuring compliance of the company with legal requirements, particularly the German Act on Employee inventions,

- in- and out-licensing of technologies.

Oct 1998 - Dec 2002

Senior Manager Intellectual Property

GPC Biotech AG (subsequently Agennix AG), a once publicly traded biopharmaceutical company formed in 1996, was focused on the development of anticancer drugs. I joined the company at a very early stage and was asked to set up a proper Patent Department, reporting to a Vice President and one of the founders of the company. My responsibilities included:

- advising senior management on Intellectual Property matters;

- conducting IP due diligence investigations, e.g. for GPC Biotech's initial public offering;

- drafting, filing, prosecution and defence of patent applications and patents before the national and international patent offices;

- ensuring compliance of the company with legal requirements, particularly the German Act on Employee inventions,

- in- and out-licensing of technologies

Connex GmbH

Dec 1996 - Aug 1998

Assistant to the Board + Manager, Intellectual Property

Connex GmbH was founded 1994 as a spin-off from the Institute for Immunology (IfI) of the Ludwig-Maximilians Universität Munich with the intent to clinically develop certain antibodies obtained by the reseachers at IfI. Additionally, it was meant to make these antibodies commercially available for research purposes. As Assistant to the Board, I was responsible for managing many aspects of the company's growth, including the contact and exchange with patent attorneys on Intellectual Property concerns. With its growth, it became increasingly evident that the company needed a full time employee for its Intellectual Property matters. This responsibility was assigned to me, and conducted the set-up of a Patent Department, soliciting advice from the company's Patent Attorneys and members of the Patent Departments of the company's clients (e.g. Schwarz Pharma)

Education

Education
Apr 1993 - Jul 2000

Ph.D.

Ph.D. Thesis: "Toxicokinetic aspects of 2,3,7,8-tetrachlorodibenzodioxin";

Advisor: Prof. Dr. Antonius Kettrup

Experimental work partly (Apr. 1993 - Jun. 1995) performed under Prof. Karl Rozman at the Department of Pharmacology and Toxicology, University of Kansas Medical Center, Kansas City, KS, USA.

Jan 1987 - Sep 1988

M.Sc./Ph.D.

Thesis work under Drs. R. St. John Manley/A. Eisenberg on blends of cellulose with ionomers

Interest

Astronomy (History of  the Universe, GUT, Quantum Physics of Spacetime), the Evolution of human behaviour, Music, Skiing

Summary

With 15 years of experience, and after having set up Patent Departments for 3 young Biotechnology firms, I count myself an expert in the needs and requirements of aspiring enterprises of the pharmaceutical and Biotechnology industry in as far as Intellectual Property is concerned. From the mundane tasks of running such department to the center court battles before international patent offices, I can advise professionally and competently.

References

References

Dr. Holger Bock

Servet Gül

Dr. Ulrich Bodner

Dr. Bernhard Virnekäs